Very recently, there have been reports in the literature of an effect of dual agonists (GIP/GLP-1) having a positive impact on glycemic control and improving insulin sensitivity, thus reducing complications related to hyperglycemia. The gene discussed is GCG; the disease is Hyperglycemia.